Glucoguard, a Division of ADHC, Completes AI Based Mobile Application and Design Outline (MADO) for Dexcom API Integration
American Diversified Holdings (ADHC) announced that its division, Glucoguard, has completed the Mobile Application and Design Outline (MADO) for Dexcom API Integration. The outline features a proprietary AI-based algorithm that forms the backbone of the Glucoguard App, designed to analyze blood sugar levels and predictively treat lows before hypoglycemic events occur.
The system integrates with Dexcom's Continuous Glucose Monitoring (CGM) technology to track glucose levels in real-time. The mobile app will connect users to the Glucoguard device, which delivers glucose when the AI algorithm detects critical changes, preventing dangerous episodes of hypoglycemia. The company will proceed with prototype development and full software/hardware integration once API integration is complete.
American Diversified Holdings (ADHC) ha annunciato che la sua divisione, Glucoguard, ha completato il Mobile Application and Design Outline (MADO) per l'integrazione dell'API Dexcom. Il design presenta un algoritmo proprietario basato sull'IA che costituisce il fulcro dell'app Glucoguard, progettata per analizzare i livelli di zucchero nel sangue e trattare in modo predittivo i valori bassi prima che si verifichino eventi ipoglicemici.
Il sistema si integra con la tecnologia di monitoraggio continuo della glicemia (CGM) di Dexcom per monitorare i livelli di glucosio in tempo reale. L'app mobile collegherà gli utenti al dispositivo Glucoguard, che fornirà glucosio quando l'algoritmo IA rileva cambiamenti critici, prevenendo episodi pericolosi di ipoglicemia. L'azienda procederà con lo sviluppo del prototipo e l'integrazione completa di software e hardware una volta completata l'integrazione dell'API.
American Diversified Holdings (ADHC) anunció que su división, Glucoguard, ha completado el Mobile Application and Design Outline (MADO) para la integración de la API de Dexcom. El esquema presenta un algoritmo propietario basado en IA que forma la columna vertebral de la app Glucoguard, diseñada para analizar los niveles de azúcar en sangre y tratar de manera predictiva los niveles bajos antes de que ocurran eventos hipoglucémicos.
El sistema se integra con la tecnología de Monitoreo Continuo de Glucosa (CGM) de Dexcom para rastrear los niveles de glucosa en tiempo real. La app móvil conectará a los usuarios con el dispositivo Glucoguard, que proporcionará glucosa cuando el algoritmo de IA detecte cambios críticos, previniendo episodios peligrosos de hipoglucemia. La compañía procederá con el desarrollo del prototipo y la integración completa de software/hardware una vez que se complete la integración de la API.
미국 다각화 홀딩스(ADHC)는 자회사인 글루코가드가 덱스컴 API 통합을 위한 모바일 애플리케이션 및 디자인 개요(MADO)를 완성했다고 발표했습니다. 이 개요는 글루코가드 앱의 근본을 형성하는 AI 기반 알고리즘을 특징으로 하며, 혈당 수준을 분석하고 저혈당 사건이 발생하기 전에 저하된 수치를 예측적으로 치료하도록 설계되었습니다.
이 시스템은 덱스컴의 지속혈당 모니터링(CGM) 기술와 통합되어 혈당 수준을 실시간으로 추적합니다. 모바일 앱은 사용자를 글루코가드 장치에 연결하여 AI 알고리즘이 중대한 변화를 감지할 때 포도당을 제공하여 위험한 저혈당 에피소드를 예방합니다. API 통합이 완료되면 회사는 프로토타입 개발과 소프트웨어/하드웨어의 완전한 통합을 진행할 것입니다.
American Diversified Holdings (ADHC) a annoncé que sa division, Glucoguard, a complété le Mobile Application and Design Outline (MADO) pour l'intégration de l'API Dexcom. Le schéma présente un algorithme propriétaire basé sur l'IA qui constitue l'épine dorsale de l'application Glucoguard, conçue pour analyser les niveaux de sucre dans le sang et traiter de manière prédictive les baisses avant que des événements hypoglycémiques ne se produisent.
Le système s'intègre à la technologie de surveillance continue du glucose (CGM) de Dexcom pour suivre les niveaux de glucose en temps réel. L'application mobile reliera les utilisateurs à l'appareil Glucoguard, qui délivre du glucose lorsque l'algorithme IA détecte des changements critiques, empêchant ainsi des épisodes dangereux d'hypoglycémie. L'entreprise procédera au développement de prototypes et à l'intégration complète du logiciel et du matériel une fois l'intégration de l'API terminée.
American Diversified Holdings (ADHC) hat angekündigt, dass seine Sparte Glucoguard den Mobile Application and Design Outline (MADO) für die Dexcom API-Integration abgeschlossen hat. Der Entwurf enthält einen proprietären KI-basierten Algorithmus, der das Rückgrat der Glucoguard-App bildet, die entwickelt wurde, um den Blutzucker zu analysieren und niedrigere Werte vor hypoglykämischen Ereignissen vorherzusagen und zu behandeln.
Das System integriert sich mit Dexcoms kontinuierlicher Glukoseüberwachung (CGM)-Technologie, um die Glukosewerte in Echtzeit zu verfolgen. Die mobile App verbindet die Nutzer mit dem Glucoguard-Gerät, das Glukose bereitstellt, wenn der KI-Algorithmus kritische Veränderungen erkennt, wodurch gefährliche Episoden von Hypoglykämie verhindert werden. Das Unternehmen wird mit der Entwicklung eines Prototyps und der vollständigen Software-/Hardware-Integration fortfahren, sobald die API-Integration abgeschlossen ist.
- Development of AI-based diabetes management system completed MADO phase
- Strategic partnership with Dexcom through Development Partner Program
- Patent-pending technology for real-time glucose monitoring and treatment
- Product still in development phase with no immediate revenue generation
- Pending regulatory approvals before commercialization
- Timeline for prototype development and integration not specified
Del Mar, California--(Newsfile Corp. - October 29, 2024) - American Diversified Holdings Corporation (OTC Pink: ADHC) announced today that Glucoguard, has competed the "MADO" Mobile Application and Design Outline as required for the Dexcom API Integration.
This outline has been submitted to the software design team to finalize the integration process through the Dexcom Development Partner Program.
The proprietary AI based algorithm outlined in the MADO is the backbone of the Glucoguard App and the foundation for the diabetes management system. The main AI component analyzes current blood sugar levels and will predictively treat lows before a potential catastrophic hypoglycemic event can occur.
Glucoguard is developing a mobile application to enable and support the functionality of the patent-pending diabetes management system. The system integrates with Dexcom's Continuous Glucose Monitoring (CGM) technology to track blood glucose levels and then respond to fluctuations in real-time, as a preemptive solution to the potential catastrophic effects of hypoglycemia.
The mobile app will serve as an essential tool for users, connecting them directly to the Glucoguard device. The device provides glucose to patients when the AI-based Algorithm detects critical changes in glucose levels, preventing dangerous episodes of Hypoglycemia (low blood sugar). By using a state-of-the-art Artificial Intelligence algorithm to ensure Glucoguard offers a best-in-class approach to diabetes management.
"Events are moving rapidly with the Glucoguard Team. Once the full API integration process is complete, we will move to prototype development and full software/hardware integration," commented Glucoguard/ADHC. "Glucoguard will soon be on the map in the diabetes management sector, utilizing AI to elevate Continuous Glucose Management to the next level treatment of diabetic patients."
Shareholders will be notified as developments are finalized in the near future.
About IMD Solutions, Inc.
IMD Solutions, Inc. is a Nevada-based medical device company developing GlucoGuard, a patent-pending nocturnal glucose monitoring and delivery system for diabetic patients. The system helps prevent the dangerous effects of low blood sugar during sleep, including the potentially fatal "Death in Bed" phenomenon. Collaborating with a leading U.S. research university, a prominent biomedical engineering firm, and a major CGM company, IMD Solutions is at the forefront of diabetes management technology.
For more information, visit: www.GlucoGuardSleep.com.
Contact: Phone: 817-525-0057
Email: info@GlucoGuardSleep.com
About AMERICAN DIVERSIFIED HOLDINGS CORPORATION
www.UniversalWellnessAI.com
www.UniversalWellnessShop.com
John Cacchioli, CEO
American Diversified Holdings Corporation
Telephone: (212) 537-5900
Email: JC@American-Diversified.com
Social Media:
TWITTER: @ADHCManagement.
This Twitter page is the only official Twitter page for ADHC.
SAFE HARBOR FORWARD-LOOKING STATEMENTS: This press release may contain forward-looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/228134
FAQ
What is the latest development milestone for ADHC's Glucoguard division?
How does ADHC's Glucoguard system work with Dexcom technology?
What are the next steps for ADHC's Glucoguard project?
